Review
Published on 07 Oct 2024
Clonal evolution: a landmark of MPN evolution
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1473920
- 568 views
Type at least 3 characters
107 articles
Articles
Review
Published on 27 Sep 2024
Recent advancements in gene therapy for sickle cell disease and β-thalassemia
in Gene Therapy, Cell Therapy and Hematology
Frontiers in Hematology
doi 10.3389/frhem.2024.1468952
- 1,145 views
Review
Published on 25 Sep 2024
Dissecting dormancy and quiescence in hematopoietic stem cells
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2024.1401713
- 415 views
Original Research
Published on 11 Sep 2024
Real-life experience with first-line treatment with daratumumab, bortezomib, melphalan, and prednisone in patients with newly diagnosed multiple myeloma ineligible for autologous stem-cell transplantation
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1438233
- 371 views
Editorial
Published on 29 Aug 2024
Editorial: Rising stars in hematopoiesis and stem cells 2023
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2024.1477997
- 282 views
Perspective
Published on 27 Aug 2024
Sickle cell disease: a comparative perspective on global and national initiatives
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2024.1457158
- 656 views
Study Protocol
Accepted on 20 Aug 2024
Comparison of 6 cycles of isatuximab with lenalidomide, bortezomib and dexamethasone (I-VRd) versus 3 cycles of I-VRd followed by one cycle of high-dose melphalan in newly diagnosed low-risk multiple myeloma. Protocol for a multicenter, prospective, randomized, phase II clinical trial (ELIAS-Trial)
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1436845
- 116 views
Editorial
Published on 14 Aug 2024
Editorial: Glycobiology in hematology: a promising avenue for cancer diagnostics and therapeutics
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1465473
- 507 views
Review
Published on 09 Aug 2024
The nexus between Helicobacter pylori infection and anemia—a systematic review
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2024.1423494
- 696 views
Review
Published on 06 Aug 2024
Are we ready to integrate 3D culture systems in acute myeloid leukemia and bone marrow microenvironment research?
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2024.1407698
- 1,173 views
Community Case Study
Published on 25 Jul 2024
Effectiveness of biosimilar pegfilgrastim in patients with lymphoma after high-dose chemotherapy and autologous stem cell transplantation: a real-life study
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1441070
- 490 views
Mini Review
Published on 22 Jul 2024
Targeting the bone marrow niche, moving towards leukemia eradication
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1429916
- 732 views
Original Research
Published on 15 Jul 2024
Real-world analysis of the underdiagnosis, clinical outcomes and associated burden of hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA) in the United States
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2024.1405311
- 1,556 views
Review
Published on 12 Jul 2024
Clonal cytopenia of undetermined significance: definitions, risk and therapeutic targets
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1419323
- 1,463 views
Case Report
Published on 10 Jul 2024
Case report: Aggressive natural killer cell leukemia and refractory hemophagocytic lymphohistiocytosis in an adolescent
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1413794
- 521 views
Review
Published on 08 Jul 2024
The sweet symphony of N-glycans in myeloid malignancies
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1415618
- 485 views